For more information about our research and other research studies, please visit the N3 Lab
Genomic Studies of OCD
The goal the project will be to identify multiple Obsessive-Compulsive Disorder (OCD) risk genes, each carrying large effects that will provide essential molecular clues to the origins of OCD and offer avenues for the development of new treatments.
This is a multi-center study with Rutgers University, University of Iowa, University of Miami, Mass General Hospital, McLean Hospital, Yale University, and Rogers Behavioral Health. We will be recruiting patients with OCD for this study and potentially their biological parents for this genetics study. This study will involve filling out questionaires regarding psychiatric/medical history, OCD symptoms, and information regarding related conditions such as tic disorder, trichotillomania, and attention deficit hyperactivity disorder (ADHD). Subsequently, a more in depth psychological evaluation may also take place. A blood draw will then be performed for this genetics study.
Please email [email protected] if you are interested in participating or have any questions about the study.
Personalized DBS for OCD Guided by Stereoencephalography Mapping
ClinicalTrials.gov Identifier: NCT06347978
We are conducting a research study into personalized deep brain stimulation (DBS) for Obsessive-Compulsive disorder (OCD) at the University of California, San Francisco (UCSF), which will be guided by invasive brain mapping.
We are looking for a total of 10 adult patients with treatment-refractory OCD.
If you are eligible and choose to be in this study, there will be three stages, including invasive brain mapping, placement of a 4-lead DBS system, and a randomized trial to determine the therapeutic effects of DBS On compared to DBS Off. Stage 3 will be followed by open label stimulation for an additional 6 months.
The total duration of the study is about 36 months. You should expect to be followed for up to 6 months beyond this point.
The purpose of this study is to determine if personalized deep brain stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes. The information we obtain in this study will be used to better understand the parts of the brain involved in Obsessive Compulsive Disorder (OCD). This study is led by Drs. A Moses Lee and Andrew Krystal.
Please email [email protected] if you are interested in participating or have any questions about the study.
Please email [email protected] if you are interested in participating or have any questions about the study.
I'm interested in this study
Improving Treatment Outcomes for Adolescents with OCD by adding Transcranial Magnetic Stimulation (TMS)
ClinicalTrials.gov Identifier: Pending
As many as 50% of children and adolescents with Obsessive Compulsive Disorder (OCD) experience continuing significant and impairing symptoms even after receiving medication and cognitive-behavioral therapy.
The goal of this pilot study is to explore if adding Transcranial Magnetic Stimulation (TMS) to ongoing treatments can lead to further improvement and even remission of OCD in teens who have experienced limited or no response to usual treatment with medication and/or cognitive-behavioral therapy (CBT).
TMS is FDA-approved for treatment resistant OCD in adults, and is safe in children and teens, but TMS has not been carefully studied in adolescent OCD.
If eligible, all adolescents in the study will receive a 3-week intensive TMS treatment under close monitoring as well as a MRI of the brain before and after TMS.
This project’s goal is to determine whether treatment with TMS administered to one of two assigned stimulation sites proves to be acceptable and shows some evidence of benefits in adolescents with OCD. The study is led by Drs. James McCracken and A Moses Lee.
Transcranial Magnetic Stimulation to Treat Compulsivity in Anorexia Nervosa
ClinicalTrials.gov Identifier: NCT06138782
Repetitive transcranial magnetic stimulation (rTMS) is being studied as a treatment for Anorexia Nervosa (AN). It involves non-invasive electromagnetic brain stimulation at the orbitofrontal cortex. TMS is also regularly used to treat other neuropsychiatric disorders such as depression and obsessive-compulsive disorder (OCD). Both AN and OCD are characterized by the propensity toward cognitive inflexibility. Since TMS is an effective FDA-cleared treatment for OCD, the researchers believe that it may also be an effective treatment for AN.
There are two groups for this study that each have a separate purpose. The purpose of the first group (ages 14 – 45) is to evaluate long-term changes in the brain specific to habit-directed networks in participants with anorexia nervosa (AN). Participants in this group will undergo functional magnetic resonance imaging (fMRI) at least 5 times over a 10-month period. Participants in this first group will not receive rTMS treatment.
The purpose of the second group (ages 18 - 45) is to determine if rTMS is effective in treating AN. Participants in this group will receive rTMS treatment for 10 days (2 consecutive weeks). Each day will involve 5 rTMS treatments over the course of 5 hours. Participants in this group will also undergo fMRI before the first TMS treatment and after the final TMS treatment.
We are currently recruiting for both groups.
Please email [email protected] if you are interested in participating or have any questions about the study.
Cortical Stimulation to Treat OCD
ClinicalTrials.gov Identifier: NCT04958096
Deep brain stimulation (DBS) is a treatment for severe, refractory OCD that is not responsive to medical and cognitive therapies. It involves the implantation of electrodes into the brain for the purpose of delivering electrical stimulation to disrupt abnormal activity that causes OCD. DBS is also regularly used to treat other neuropsychiatric disorders such as Parkinson's disease, other movement disorders, and epilepsy. While DBS is effective for many patients, approximately 30% of patients do not respond at the existing DBS subcortical target, which is in the ventral capsule/ventral striatum (VC/VS) region.
The purpose of this study is to investigate novel cortical targets for brain stimulation to treat OCD and to identify abnormal brain signals associated with OCD and psychiatric symptoms. While treating OCD with standard deep brain stimulation (DBS) therapy, additional electrodes will be implanted in the anterior cingulate and prefrontal cortex, regions known be involved with OCD, for the purposes of identify OCD-related signals and to determine whether stimulation delivered to these parts of the brain in addition to the subcortical VC/VS can improve OCD symptoms.
We are currently recruiting adults 22 and older with severe OCD (YBOCS>=28) to participate. To be eligible, patients must have trialed:
- at least 2 SSRIs at adequate doses
- augmentation with an antipsychotic
- Clomipramine
- at least 6 months of exposure response prevention therapy or have undergone an intensive therapy program
Please email [email protected] if you are interested in participating or have any questions about the study.
Brain Biomarkers of OCD During a Decision-Making Task
We are conducting an imaging study to better understand how brain activity differs in individuals with Obsessive Compulsive Disorder (OCD). We are particularly interested to know if OCD affects how the brain processes rewards and chooses between options to attain goals, a set of functions known in neuroscience as cognitive control. To study this we are using functional magnetic imaging (fMRI) to scan the brains of people with and without OCD while they play a simple video-game-like task. fMRI uses magnetic fields to detect relative oxygenation of blood in the brain. By measuring this, called the Blood Oxygen Level Dependent (BOLD) signal, in different parts of the brain during the task, and comparing those measurements between OCD and control groups, we will see if particular events in the task are associated with more or less activation in certain brain areas in individuals with OCD compared to controls. We are particularly interested in parts of the brain called the Anterior Cingulate Cortex (ACC) and the Dorsolateral Prefrontal Cortex (DLPFC), areas which have been previously been implicated in OCD. Our task is a computer-based game in which participants try to win money by choosing between options that differ in terms of their relative likelihood of yielding a reward.
For each participant the study has three stages. First your complete a brief online screening survey to determine your level of OCD symptoms. Second you play the game on your own online in order to get used to the game and interface. Finally, after completing the online game, you will be asked to come to UCSF Mission Bay campus and play the game while the fMRI scanner is running. The fMRI scan is a 1.5-2 hour commitment and will occur Monday - Friday between 8-6 and involves lying still in a small space for up to an hour. Participants will be compensated for each stage of the study.